Manilkara zapota (L.) P. Royen Leaf Mitigates Colitis-Associated Colon Cancer through Anti-inflammatory Modulation in BALB/C Mice

Colitis-associated colon cancer (CAC) arises from prolonged inflammation of the inner colon lining. An alternative approach to treating or preventing CAC involves the use of natural products such as Manilkara zapota (L.) P. Royen or M. zapota, which has been studied for its medicinal and pharmacolog...

Full description

Saved in:
Bibliographic Details
Main Authors: Norain Mohd Tamsir (Author), Norhaizan Mohd Esa (Author), Nurul Husna Shafie (Author), Hazilawati Hamzah (Author)
Format: Book
Published: Hindawi Limited, 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8aa3d0aee36b42538d8c9952152c84e1
042 |a dc 
100 1 0 |a Norain Mohd Tamsir  |e author 
700 1 0 |a Norhaizan Mohd Esa  |e author 
700 1 0 |a Nurul Husna Shafie  |e author 
700 1 0 |a Hazilawati Hamzah  |e author 
245 0 0 |a Manilkara zapota (L.) P. Royen Leaf Mitigates Colitis-Associated Colon Cancer through Anti-inflammatory Modulation in BALB/C Mice 
260 |b Hindawi Limited,   |c 2024-01-01T00:00:00Z. 
500 |a 2633-4690 
500 |a 10.1155/2024/1137696 
520 |a Colitis-associated colon cancer (CAC) arises from prolonged inflammation of the inner colon lining. An alternative approach to treating or preventing CAC involves the use of natural products such as Manilkara zapota (L.) P. Royen or M. zapota, which has been studied for its medicinal and pharmacological properties. Previous research has demonstrated the anticancer effects of M. zapota leaf aqueous extract (MZLAE) on colon cancer cells. However, no animal study has investigated the effects of MZLAE on CAC. Therefore, this study aimed to assess the potential anti-inflammatory effects of MZLAE on CAC in mice. In the present study, CAC was induced using azoxymethane (AOM) and dextran sodium sulphate (DSS). The mice were randomly assigned into five groups: (a) normal, (b) AOM/DSS, (c) AOM/DSS + 50 mg/kg MZLAE, (d) AOM/DSS + 100 mg/kg MZLAE, and (e) AOM/DSS + 200 mg/kg MZLAE. Various parameters including disease activity index (DAI), colon length and weight, reactive oxygen species (ROS), superoxide, superoxide dismutase (SOD), histopathological assessment, and proinflammatory cytokines expression were analysed. The results indicated that MZLAE improved DAI scores, colon length, colon histological dysplasia and inflammation scores, and SOD level, while also reducing ROS production and expression of proinflammatory cytokines (tumour necrosis factor-alpha (TNF- α) and interleukin 6 (IL-6)). In conclusion, this study suggests that MZLAE may serve as a promising source of antioxidants and anti-inflammatory agents for alleviating CAC. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Advances in Pharmacological and Pharmaceutical Sciences, Vol 2024 (2024) 
787 0 |n http://dx.doi.org/10.1155/2024/1137696 
787 0 |n https://doaj.org/toc/2633-4690 
856 4 1 |u https://doaj.org/article/8aa3d0aee36b42538d8c9952152c84e1  |z Connect to this object online.